POPPI, LAURA
 Distribuzione geografica
Continente #
EU - Europa 201
NA - Nord America 100
AS - Asia 69
AF - Africa 6
OC - Oceania 1
Totale 377
Nazione #
IT - Italia 119
US - Stati Uniti d'America 91
IN - India 27
GB - Regno Unito 19
CN - Cina 13
IE - Irlanda 12
SE - Svezia 10
CH - Svizzera 8
CA - Canada 7
SG - Singapore 7
KR - Corea 6
BG - Bulgaria 5
DE - Germania 5
ES - Italia 5
FR - Francia 5
HK - Hong Kong 5
NL - Olanda 5
AT - Austria 3
TG - Togo 3
TW - Taiwan 3
AE - Emirati Arabi Uniti 2
GR - Grecia 2
JO - Giordania 2
MX - Messico 2
NG - Nigeria 2
TR - Turchia 2
AU - Australia 1
FI - Finlandia 1
JP - Giappone 1
PH - Filippine 1
PT - Portogallo 1
UA - Ucraina 1
ZA - Sudafrica 1
Totale 377
Città #
Bologna 43
Chandler 18
Genoa 13
Dublin 12
Milan 11
Ashburn 8
Nerviano 8
Bengaluru 7
Exeter 7
Hyderabad 7
Carlsbad 6
Cento 6
New York 6
Amsterdam 5
Sofia 5
Southend 5
Wanchai 5
Chandigarh 4
Chantilly 4
Québec 4
Singapore 4
Zurich 4
Bern 3
Chions 3
Donostia / San Sebastian 3
Forlì 3
Isola della Scala 3
Lomé 3
Modena 3
Redmond 3
Vienna 3
Abeokuta 2
Amman 2
Athens 2
Carpi 2
Clapiers 2
Coyoacán 2
Erode 2
Fairfax 2
Gansevoort 2
Hamyang-gun 2
Istanbul 2
Kaohsiung City 2
Montreal 2
Mumbai 2
Navi Mumbai 2
Northolt 2
Novara 2
Paris 2
Peterborough 2
Princeton 2
Sirone 2
Songpa-gu 2
Barcelona 1
Beijing 1
Berkhamsted 1
Berlin 1
Bozzolo 1
Bremblens 1
Bremen 1
Canaro 1
Chieti 1
Des Moines 1
Florence 1
Giussano 1
Hebei 1
Helsinki 1
Jinan 1
Kakinada 1
London 1
Medford 1
Monza 1
Mülheim 1
North Bergen 1
Palermo 1
Rome 1
Salford 1
San Jose 1
Santa Maria 1
Sanxia District 1
Seoul 1
Shanghai 1
Sydney 1
Tianjin 1
Tokyo 1
Toronto 1
Turin 1
Ulsan 1
Westminster 1
Totale 299
Nome #
A RAD51/BRCA2 small molecule inhibitor enhances the antineoplastic effect of the PARPi talazoparib in pancreatic cancer 150
HIPPO AND NECROPTOSIS PATHWAYS AS POSSIBLE PLAYERS IN THE NEURONOPATHIC GAUCHER 90
Insights into the activity of ARN24089, a new RAD51-BRCA2 disruptor that inhibits homologous recombination and achieves synthetic lethality in pancreatic cancer 49
Identification and subsequent development of RAD51-BRCA2 disruptors through a fragment-based approach 39
The Mechanistic Understanding of RAD51 Defibrillation: A Critical Step in BRCA2-Mediated DNA Repair by Homologous Recombination 39
An 19F NMR fragment-based approach for the discovery and development of BRCA2-RAD51 inhibitors to pursuit synthetic lethality in combination with PARP inhibition in pancreatic cancer 21
A journey through targeting BRCA2-RAD51 protein-protein interaction to establish synthetic lethality as paradigm for anticancer drug discovery 1
Proteomic profile of BxPC-3 cells after treatment with BRC4 1
Totale 390
Categoria #
all - tutte 864
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 864


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202013 0 0 0 0 5 0 0 4 0 3 1 0
2020/202111 3 0 1 0 1 0 0 3 1 1 0 1
2021/202218 1 0 1 4 1 1 0 0 2 0 4 4
2022/202399 4 6 1 6 25 6 6 1 6 1 4 33
2023/2024249 70 26 10 15 22 15 32 22 7 18 12 0
Totale 390